Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-07-31
DOI
10.3389/fimmu.2017.00867
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell-type–restricted anti-cytokine therapy: TNF inhibition from one pathogenic source
- (2016) Grigory A. Efimov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Loss of Response to Anti-TNFs: Definition, Epidemiology and Management
- (2016) Giulia Roda et al. Clinical and Translational Gastroenterology
- Camelid nanobodies: killing two birds with one stone
- (2015) Aline Desmyter et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- TNF biology, pathogenic mechanisms and emerging therapeutic strategies
- (2015) George D. Kalliolias et al. Nature Reviews Rheumatology
- Generation and Characterization of Small Single Domain Antibodies Inhibiting Human Tumor Necrosis Factor Receptor 1
- (2014) Sophie Steeland et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nanobodies as novel agents for disease diagnosis and therapy
- (2013) Christina G. Siontorou International Journal of Nanomedicine
- Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1
- (2011) Filip Van Hauwermeiren et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules
- (2011) Anna Hultberg et al. PLoS One
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- TNF receptor 2 pathway: drug target for autoimmune diseases
- (2010) Denise Faustman et al. NATURE REVIEWS DRUG DISCOVERY
- CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells
- (2010) S. Jahnichen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular replacement withMOLREP
- (2009) Alexei Vagin et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Predicting the future of anti-tumor necrosis factor therapy
- (2009) Cornelis L Verweij ARTHRITIS RESEARCH & THERAPY
- Dendritic cells and cytokines in human inflammatory and autoimmune diseases
- (2008) P BLANCO et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120
- (2008) A. Forsman et al. JOURNAL OF VIROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now